Internal Medicine, Nephrology · Tupelo, MS
NPI
1689644510
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1542 Medical Park Cir
Tupelo, MS, 38801
Phone (662) 844-4711
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
3,455 services
Medicare patients, 2024
510
Average age 71
Drug cost, 2024
$317K
895 prescriptions
Company payments, 2025
$58.16
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tzonko V Milev was code 36415 (venipuncture blood collection), 427 times for 255 patients. In total Tzonko V Milev billed 3,455 services in 26 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 427 | 255 | $8.58 | $3,665 |
| 85025 Blood Count | Office | 417 | 254 | $7.58 | $3,161 |
| 81002 Clinical Chemistry | Office | 401 | 254 | $3.40 | $1,362 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 386 | 240 | $11.26 | $4,345 |
| 80069 Clinical Chemistry | Office | 382 | 225 | $8.48 | $3,239 |
| 90960 ESRD Related Services (not dialysis) | Office | 382 | 54 | $254.14 | $97K |
| 99214 Office E&M - Established | Office | 353 | 239 | $46.37 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 137 | 68 | $85.80 | $12K |
| 90935 Hemodialysis | Facility | 89 | 63 | $51.35 | $4,570 |
| 99223 Hospital E&M - Initial | Facility | 76 | 74 | $126.98 | $9,650 |
| 99215 Office E&M - Established | Office | 70 | 57 | $89.12 | $6,239 |
| 90961 ESRD Related Services (not dialysis) | Office | 63 | 30 | $213.40 | $13K |
| 99222 Hospital E&M - Initial | Facility | 34 | 33 | $92.72 | $3,152 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 33 | $57.72 | $1,962 |
| 80053 Clinical Chemistry | Office | 32 | 31 | $10.35 | $331 |
By year: 2022 $193K for 3,818 services; 2023 $224K for 3,712 services; 2024 $195K for 3,455 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 427 | 255 | $8.58 | $3,665 |
| 85025 Blood Count | 417 | 254 | $7.58 | $3,161 |
| 81002 Clinical Chemistry | 401 | 254 | $3.40 | $1,362 |
| 80069 Clinical Chemistry | 382 | 225 | $8.48 | $3,239 |
| 80053 Clinical Chemistry | 32 | 31 | $10.35 | $331 |
| 84100 Clinical Chemistry | 32 | 31 | $4.65 | $149 |
Medicare prescription drug claims, 2024
In 2024, the drug Tzonko V Milev prescribed most often to Medicare patients was Sevelamer Carbonate, with 103 prescriptions and refills. In total Tzonko V Milev wrote 895 Medicare prescriptions that cost $317K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 103 | 113 | 29 | $11K |
| Calcium Acetate Generic | 66 | 68 | 17 | $2,776 |
| Guanfacine Hcl Generic | 63 | 116 | 19 | $3,388 |
| Losartan Potassium Generic | 57 | 117 | 16 | $485 |
| Auryxia Ferric Citrate | 54 | 54 | 13 | $84K |
| Furosemide Generic | 47 | 91 | 12 | $114 |
| Amlodipine Besylate Generic | 45 | 93 | 14 | $161 |
| Potassium Chloride Generic | 29 | 43 | Under 11 | $235 |
| Carvedilol Generic | 29 | 78 | 11 | $168 |
| Velphoro Sucroferric Oxyhydroxide | 28 | 28 | 11 | $54K |
| Hydrochlorothiazide Generic | 19 | 39 | Under 11 | $32.73 |
| Lisinopril Generic | 18 | 46 | Under 11 | $59.27 |
| Lokelma Sodium Zirconium Cyclosilicate | 17 | 21 | Under 11 | $17K |
| Cinacalcet Hcl Generic | 16 | 26 | Under 11 | $539 |
| Metoprolol Succinate Generic | 15 | 17 | Under 11 | $162 |
Brand drugs: 164 claims; generic drugs: 731 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tzonko V Milev $58.16 ($58.16 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novartis Pharmaceuticals Corporation with $21.02.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.